KOSDAQ large cap
Seegene
A leading Korean molecular diagnostics company supplying syndromic multiplex PCR assays and instruments worldwide. KOSDAQ large-cap constituent. Baseline node ahead of value-chain research; promoted to a full node once AI question demand is observed.
096530.KQ Updated Jul 11, 2026 2 AI consumers· 1 recurring
Annual return · 2026-07-10'21-33.1%'22-48.7%'23-3.7%'24-3.3%'25+25.7%YTD+2.7%
Money in ▸·
Seegene
▸ Money out·
Financials & Segments
- Segments · Molecular-diagnostic reagents · Diagnostic instruments/others
Revenue from
No refined links yet.
Pays to
No refined links yet.